We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia.
- Authors
Smolewski, Piotr; Witkowska, Magdalena; Korycka-Wołowiec, Anna
- Abstract
Chronic lymphocytic leukemia (CLL) is characterized by the clonal proliferation and accumulation of mature B lymphocytes. CLL cells show an antiapoptotic profile, suggesting the important role of apoptosis inhibition in the disease development. However, there is some population of proliferating CLL cells, which may also play a role in progression of the disease. There are several newer, biological prognostic factors in CLL. Currently, cytogenetic abnormalities with different prognostic values seem to be the most biologically relevant. During the last decades, the treatment of CLL has been significantly changed. Different strategies such as monotherapy with chlorambucil and purine nucleoside analogues (PNA) used alone or in combination with cyclophosphamide have been introduced. Most recently, immunochemotherapy with anti-CD20 monoclonal antibody, rituximab, combined with fludarabine and cyclophosphamide, became a gold standard of first-line treatment in eligible CLL patients. Currently, new treatment strategies including new monoclonal antibodies, bendamustine, lenalidomide, or inhibitors of several cell signaling pathways are under clinical studies in resistant/relapsed CLL patients. Moreover, allogeneic stem cell transplantation has to be considered, especially in younger high risk patients, for example, those who are resistant to PNA or those with 17p deletion. In this paper, we present the most important recent advances in CLL biology and treatment.
- Subjects
ANTINEOPLASTIC agents; CHRONIC lymphocytic leukemia treatment; STEM cell transplantation; APOPTOSIS; CHRONIC lymphocytic leukemia; IMMUNOTHERAPY; PROGNOSIS; RESEARCH funding
- Publication
ISRN Oncology, 2013, p1
- ISSN
2090-5661
- Publication type
Article
- DOI
10.1155/2013/740615